Nuclear localization of lymphocyte-specific protein tyrosine kinase (Lck) and its role in regulating LIM domain only 2 (Lmo2) gene

Biochemical and Biophysical Research Communications

Volumn 417, Issue 3, 2012, Pages 1058-1062

  Venkitachalam, Srividya ^a   Chueh, Fu Yu ^a   Yu, Chao Lan ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Gene regulation; Lck; Lmo2; Nuclear localization; Protein tyrosine kinase

Indexed keywords

HISTONE H3; JANUS KINASE 2; LIM DOMAIN ONLY PROTEIN 2; PROTEIN KINASE LCK; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME BINDING; GENE CONTROL; GENE TRANSLOCATION; HISTONE PHOSPHORYLATION; IMMUNOFLUORESCENCE MICROSCOPY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; T CELL LEUKEMIA;

ACTIVE TRANSPORT, CELL NUCLEUS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE, TUMOR; CELL NUCLEUS; GENE EXPRESSION REGULATION, LEUKEMIC; HEK293 CELLS; HUMANS; LIM DOMAIN PROTEINS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MICE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; TRANSCRIPTIONAL ACTIVATION;

EID: 84856019851     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.095     Document Type: Article

References (27)

1. McCormack M.P., Rabbitts T.H. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 2004, 350:913-922.
2. Nam C.H., Rabbitts T.H. The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion. Mol. Ther. 2006, 13:15-25.
3. Oram S.H., Thoms J.A., Pridans C., Janes M.E., Kinston S.J., Anand S., Landry J.R., Lock R.B., Jayaraman P.S., Huntly B.J., Pimanda J.E., Gottgens B. A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients. Oncogene 2010, 29:5796-5808.
4. Rabbitts T.H., Axelson H., Forster A., Grutz G., Lavenir I., Larson R., Osada H., Valge-Archer V., Wadman I., Warren A. Chromosomal translocations and leukaemia: a role for LMO2 in T cell acute leukaemia, in transcription and in erythropoiesis. Leukemia 1997, 11(Suppl. 3):271-272.
5. Landry J.R., Kinston S., Knezevic K., Donaldson I.J., Green A.R., Gottgens B. Fli1, Elf1, and Ets1 regulate the proximal promoter of the LMO2 gene in endothelial cells. Blood 2005, 106:2680-2687.
6. Dawson M.A., Bannister A.J., Gottgens B., Foster S.D., Bartke T., Green A.R., Kouzarides T. JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature 2009, 461:819-822.
7. Sefton B.M. The lck tyrosine protein kinase. Oncogene 1991, 6:683-686.
8. Palacios E.H., Weiss A. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 2004, 23:7990-8000.
9. Marth J.D., Disteche C., Pravtcheva D., Ruddle F., Krebs E.G., Perlmutter R.M. Localization of a lymphocyte-specific protein tyrosine kinase gene (lck) at a site of frequent chromosomal abnormalities in human lymphomas. Proc. Natl. Acad. Sci. USA 1986, 83:7400-7404.
10. Majolini M.B., Boncristiano M., Baldari C.T. Dysregulation of the protein tyrosine kinase LCK in lymphoproliferative disorders and in other neoplasias. Leuk. Lymphoma 1999, 35:245-254.
11. Wright D.D., Sefton B.M., Kamps M.P. Oncogenic activation of the Lck protein accompanies translocation of the LCK gene in the human HSB2 T-cell leukemia. Mol. Cell. Biol. 1994, 14:2429-2437.
12. Martin G.S. The hunting of the Src. Nat. Rev. Mol. Cell Biol. 2001, 2:467-475.
13. Amrein K.E., Sefton B.M. Mutation of a site of tyrosine phosphorylation in the lymphocyte-specific tyrosine protein kinase, p56lck, reveals its oncogenic potential in fibroblasts. Proc. Natl. Acad. Sci. USA 1988, 85:4247-4251.
14. Marth J.D., Cooper J.A., King C.S., Ziegler S.F., Tinker D.A., Overell R.W., Krebs E.G., Perlmutter R.M. Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56lck). Mol. Cell. Biol. 1988, 8:540-550.
15. Yu C.-L., Jove R., Burakoff S.J. Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase. J. Immunol. 1997, 159:5206-5210.
16. Shi M., Cooper J.C., Yu C.-L. A constitutively active Lck kinase promotes cell proliferation and resistance to apoptosis through signal transducer and activator of transcription 5b activation. Mol. Cancer Res. 2006, 4:39-45.
17. Salmond R.J., Filby A., Qureshi I., Caserta S., Zamoyska R. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol. Rev. 2009, 228:9-22.
18. Takahashi A., Obata Y., Fukumoto Y., Nakayama Y., Kasahara K., Kuga T., Higashiyama Y., Saito T., Yokoyama K.K., Yamaguchi N. Nuclear localization of Src-family tyrosine kinases is required for growth factor-induced euchromatinization. Exp. Cell Res. 2009, 315:1117-1141.
19. Ikeda K., Nakayama Y., Togashi Y., Obata Y., Kuga T., Kasahara K., Fukumoto Y., Yamaguchi N. Nuclear localization of Lyn tyrosine kinase mediated by inhibition of its kinase activity. Exp. Cell Res. 2008, 314:3392-3404.
20. Jaganathan S., Yue P., Paladino D.C., Bogdanovic J., Huo Q., Turkson J. A functional nuclear epidermal growth factor receptor, SRC and Stat3 heteromeric complex in pancreatic cancer cells. PLoS One 2011, 6:e19605.
21. Chueh F.-Y., Leong K.-F., Yu C.-L. Mitochondrial translocation of signal transducer and activator of transcription 5 (STAT5) in leukemic T cells and cytokine-stimulated cells. Biochem. Biophys. Res. Commun. 2010, 402:778-783.
22. Chueh F.-Y., Leong K.-F., Cronk R.J., Venkitachalam S., Pabich S., Yu C.-L. Nuclear localization of pyruvate dehydrogenase complex-E2 (PDC-E2), a mitochondrial enzyme, and its role in signal transducer and activator of transcription 5 (STAT5)-dependent gene transcription. Cell Signal. 2011, 23:1170-1178.
23. Venkitachalam S., Chueh F.-Y., Leong K.-F., Pabich S., Yu C.-L. Suppressor of cytokine signaling 1 interacts with oncogenic lymphocyte-specific protein tyrosine kinase. Oncol. Rep. 2011, 25:677-683.
24. Yurchak L.K., Hardwick J.S., Amrein K., Pierno K., Sefton B.M. Stimulation of phosphorylation of Tyr394 by hydrogen peroxide reactivates biologically inactive, non-membrane-bound forms of Lck. J. Biol. Chem. 1996, 271:12549-12554.
25. Ahmed Z., Beeton C.A., Williams M.A., Clements D., Baldari C.T., Ladbury J.E. Distinct spatial and temporal distribution of ZAP70 and Lck following stimulation of interferon and T-cell receptors. J. Mol. Biol. 2005, 353:1001-1010.
26. Chakraborty G., Rangaswami H., Jain S., Kundu G.C. Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis. J. Biol. Chem. 2006, 281:11322-11331.
27. Svensson S., Jirström K., Rydén L., Roos G., Emdin S., Ostrowski M.C., Landberg G. ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis. Oncogene 2005, 24:4370-4379.